vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Nextpower Inc. (NXT). Click either name above to swap in a different company.

Nextpower Inc. is the larger business by last-quarter revenue ($909.4M vs $487.7M, roughly 1.9× CLOVER HEALTH INVESTMENTS, CORP.). Nextpower Inc. runs the higher net margin — 14.4% vs -10.1%, a 24.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 33.9%). Nextpower Inc. produced more free cash flow last quarter ($118.5M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 11.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Nextpower Inc. (NXT) is a global energy technology provider based in Fremont, California.

CLOV vs NXT — Head-to-Head

Bigger by revenue
NXT
NXT
1.9× larger
NXT
$909.4M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+10.9% gap
CLOV
44.7%
33.9%
NXT
Higher net margin
NXT
NXT
24.5% more per $
NXT
14.4%
-10.1%
CLOV
More free cash flow
NXT
NXT
$187.5M more FCF
NXT
$118.5M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
11.1%
NXT

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
NXT
NXT
Revenue
$487.7M
$909.4M
Net Profit
$-49.3M
$131.2M
Gross Margin
31.7%
Operating Margin
-10.1%
19.4%
Net Margin
-10.1%
14.4%
Revenue YoY
44.7%
33.9%
Net Profit YoY
-123.2%
13.8%
EPS (diluted)
$0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
NXT
NXT
Q4 25
$487.7M
$909.4M
Q3 25
$496.6M
$905.3M
Q2 25
$477.6M
$864.3M
Q1 25
$462.3M
$924.3M
Q4 24
$337.0M
$679.4M
Q3 24
$331.0M
$635.6M
Q2 24
$356.3M
$719.9M
Q1 24
$346.9M
$736.5M
Net Profit
CLOV
CLOV
NXT
NXT
Q4 25
$-49.3M
$131.2M
Q3 25
$-24.4M
$146.9M
Q2 25
$-10.6M
$157.2M
Q1 25
$-1.3M
$156.8M
Q4 24
$-22.1M
$115.3M
Q3 24
$-9.2M
$115.4M
Q2 24
$7.4M
$121.7M
Q1 24
$-19.2M
$205.2M
Gross Margin
CLOV
CLOV
NXT
NXT
Q4 25
31.7%
Q3 25
32.4%
Q2 25
32.6%
Q1 25
33.1%
Q4 24
35.5%
Q3 24
24.5%
35.4%
Q2 24
30.3%
33.0%
Q1 24
23.6%
46.2%
Operating Margin
CLOV
CLOV
NXT
NXT
Q4 25
-10.1%
19.4%
Q3 25
-4.9%
20.0%
Q2 25
-2.2%
21.5%
Q1 25
-0.3%
21.1%
Q4 24
-6.4%
22.1%
Q3 24
-2.7%
21.0%
Q2 24
2.0%
22.2%
Q1 24
-6.5%
36.8%
Net Margin
CLOV
CLOV
NXT
NXT
Q4 25
-10.1%
14.4%
Q3 25
-4.9%
16.2%
Q2 25
-2.2%
18.2%
Q1 25
-0.3%
17.0%
Q4 24
-6.6%
17.0%
Q3 24
-2.8%
18.2%
Q2 24
2.1%
16.9%
Q1 24
-5.5%
27.9%
EPS (diluted)
CLOV
CLOV
NXT
NXT
Q4 25
$0.85
Q3 25
$0.97
Q2 25
$1.04
Q1 25
$1.05
Q4 24
$0.79
Q3 24
$0.79
Q2 24
$0.84
Q1 24
$1.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
NXT
NXT
Cash + ST InvestmentsLiquidity on hand
$78.3M
$952.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$2.2B
Total Assets
$541.0M
$3.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
NXT
NXT
Q4 25
$78.3M
$952.6M
Q3 25
$845.3M
Q2 25
$743.4M
Q1 25
$766.1M
Q4 24
$194.5M
$693.5M
Q3 24
$288.0M
$561.9M
Q2 24
$254.8M
$471.9M
Q1 24
$208.3M
$474.1M
Stockholders' Equity
CLOV
CLOV
NXT
NXT
Q4 25
$308.7M
$2.2B
Q3 25
$340.9M
$2.0B
Q2 25
$344.2M
$1.8B
Q1 25
$336.1M
$1.6B
Q4 24
$341.1M
$1.4B
Q3 24
$342.2M
$1.3B
Q2 24
$324.9M
$1.1B
Q1 24
$292.5M
$961.0M
Total Assets
CLOV
CLOV
NXT
NXT
Q4 25
$541.0M
$3.8B
Q3 25
$559.7M
$3.7B
Q2 25
$575.0M
$3.4B
Q1 25
$583.7M
$3.2B
Q4 24
$580.7M
$3.0B
Q3 24
$653.0M
$2.8B
Q2 24
$674.2M
$2.6B
Q1 24
$671.8M
$2.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
NXT
NXT
Operating Cash FlowLast quarter
$-66.9M
$123.3M
Free Cash FlowOCF − Capex
$-69.0M
$118.5M
FCF MarginFCF / Revenue
-14.1%
13.0%
Capex IntensityCapex / Revenue
0.4%
0.5%
Cash ConversionOCF / Net Profit
0.94×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$587.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
NXT
NXT
Q4 25
$-66.9M
$123.3M
Q3 25
$12.1M
$186.9M
Q2 25
$5.4M
$81.3M
Q1 25
$-16.3M
$237.3M
Q4 24
$34.8M
$143.8M
Q3 24
$50.0M
$153.8M
Q2 24
$44.8M
$120.8M
Q1 24
$25.9M
$111.5M
Free Cash Flow
CLOV
CLOV
NXT
NXT
Q4 25
$-69.0M
$118.5M
Q3 25
$11.4M
$171.4M
Q2 25
$4.8M
$70.1M
Q1 25
$-16.5M
$227.2M
Q4 24
$33.3M
$134.9M
Q3 24
$49.6M
$141.8M
Q2 24
$44.4M
$118.0M
Q1 24
$25.5M
$109.2M
FCF Margin
CLOV
CLOV
NXT
NXT
Q4 25
-14.1%
13.0%
Q3 25
2.3%
18.9%
Q2 25
1.0%
8.1%
Q1 25
-3.6%
24.6%
Q4 24
9.9%
19.9%
Q3 24
15.0%
22.3%
Q2 24
12.5%
16.4%
Q1 24
7.3%
14.8%
Capex Intensity
CLOV
CLOV
NXT
NXT
Q4 25
0.4%
0.5%
Q3 25
0.1%
1.7%
Q2 25
0.1%
1.3%
Q1 25
0.0%
1.1%
Q4 24
0.5%
1.3%
Q3 24
0.1%
1.9%
Q2 24
0.1%
0.4%
Q1 24
0.1%
0.3%
Cash Conversion
CLOV
CLOV
NXT
NXT
Q4 25
0.94×
Q3 25
1.27×
Q2 25
0.52×
Q1 25
1.51×
Q4 24
1.25×
Q3 24
1.33×
Q2 24
6.04×
0.99×
Q1 24
0.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

NXT
NXT

Transferred Over Time$763.9M84%
Transferred At Point In Time$145.4M16%

Related Comparisons